Incyte Corporation
(Public, NASDAQ:INCY) Watch this stockFind more results for
INCY:NASDAQ
Advertisement
Events
Nov 5, 2009
Q3 2009 Earnings Conference Call -
Nov 5, 2009
Q3 2009 Earnings Release
Oct 5, 2009
JMP Securities Healthcare Focus Conference -
Sep 21, 2009
UBS Global Life Sciences Conference -
Sep 15, 2009
Morgan Stanley Global Healthcare Conference -
Sep 9, 2009
Robert W. Baird & Co., Inc. Health Care Conference -
|
More events from AOL Finance »
|
Key stats and ratios
| Q3 (Sep '09) | 2008 | |
| Net profit margin | -4617.36% | -4565.45% |
| Operating margin | -3933.01% | -4064.53% |
| EBITD margin | - | -3975.22% |
| Return on average assets | -55.05% | -70.43% |
| Return on average equity | - | - |
| Employees | 212 | - |
Address
Experimetal Station Route 141 & Henry Clay Rd. Building E336
Wilmington, DE 19880
United States - Map
+1-302-4986700 (Phone)
+1-302-4252750 (Fax)
Wilmington, DE 19880
United States - Map
+1-302-4986700 (Phone)
+1-302-4252750 (Fax)
Website links
Company website:
http://www.incyte.com/
http://www.incyte.com/
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com
Incyte Corporation discussions
View all discussions »Description
Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation and diabetes. Incyte’s pipeline includes compounds in various stages of development in the areas of oncology, inflammation, diabetes and human immunodeficiency virus (HIV).
Officers and directors
| Richard U. De Schutter | Chairman of the Board | |
| Paul A. Friedman M.D. | President, Chief Executive Officer, Director | |
| David C. Hastings | Chief Financial Officer, Executive Vice President | |
| Patricia A. Schreck | Executive Vice President, General Counsel | |
| Paula J. Swain | Executive Vice President - Human Resources | |
| Brian W. Metcalf Ph.D. | Executive Vice President, Chief Drug Discovery Scientist | |
| Richard S. Levy M.D. | Executive Vice President, Chief Drug Development and Medical Officer | |
| Patricia S. Andrews | Executive Vice President, Chief Commercial Officer | |
| Steven M. Friedman M.D. | Executive Vice President - Biology and Preclinical Development | |
| Roy A. Whitfield | Director |